Business
EU regulators reviewing J&J’s COVID vaccine after blood clots – Aljazeera.com
Johnson & Johnson is working with EU regulators to assess data on the rare clots, the company said in a statement.
The European Unions drug regulator has started a review to assess blood clots in people who received Johnson & Johnsons Covid-19 vaccine.
Four serious cases of unusual clots accompanied by low blood platelets, one of which was fatal, have emerged after immunization with the J&J shot, the European Medicines Agency said Friday. The regulator is now scrutinizing potential safety issues for two Covid vaccines, after AstraZeneca Plcs shot was possibly linked to a rare blood-clotting disorder.
J&J is…
-
Noosa News23 hours agoInside the final hours before Australian lawyer Christopher Saines died in Thai massage parlour
-
General21 hours agoGerman backpacker Carolina Wilga found alive in WA’s outback
-
Noosa News23 hours agoGrow it local | Noosa Today
-
Noosa News23 hours agoAustralian NFL player Laki Tasi comes home to convince kids to switch codes